Tuberculosis (TB) remains the leading cause of mortality from infectious diseases. Extended
TB treatment and frequent adverse effects, due to poor bioavailability of anti-tubercular …

Liposomes are reputed colloidal vehicles that hold the promise for targeted delivery of anti-
tubercular drugs (ATBDs) to alveolar macrophages that host Mycobacterium tuberculosis …

Liposomes are considered as potential vehicles for the delivery of anti-tuberculosis drugs
(ATBD) due to their rapid uptake by alveolar macrophages, where the mycobacterium often …

Isoniazid (INH) is a first line drug for treatment of the widespread deadly disease caused by
Mycobacterium tuberculosis. Peptide conjugate of INH was designed and synthesised for …

An inclusion complex of isoniazid-grafted phthalocyanine with gamma-cyclodextrin
(Complex) was co-encapsulated with rifampicin (RIF) in crude soybean lecithin liposomes …

Background: Mycobacterium tuberculosis (M. TB) remains the prime cause of bacterial
mortality and morbidity world-wide. Therefore, effective delivery and targeting of drug to the …

Considering that Mycobacterium tuberculosis (Mtb) can survive in host phagocytes for
decades and currently applied drugs are largely ineffective in killing intracellular Mtb, novel …

Tuberculosis (TB) remains one of the oldest and deadliest diseases in the current scenario.
The intracellular organism Mycobacterium tuberculosis, which mainly resides in …

The packaging of antimicrobials/chemotherapeutics into nanoliposomes can enhance their
activity while minimizing toxicity. However, their use is still limited owing to …

Tuberculosis (TB) is an infectious disease that annually affects millions of people, and
resistance to available antibiotics has exacerbated this situation. Another notable …